| Bioactivity | PCSK9-IN-16 is a potent PCSK9 inhibitor. PCSK9-IN-16 is extracted from patent WO2020150474, example 87, has the potential for hypercholesterolemia and other cardiovascular diseases research[1]. |
| Name | PCSK9-IN-16 |
| CAS | 2455424-51-6 |
| Formula | C16H20N6O2S3 |
| Molar Mass | 424.56 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Michael H, et al. Pcsk9 inhibitors and methods of use thereof. Patent WO2020150474 |
PCSK9-IN-16
CAS: 2455424-51-6 F: C16H20N6O2S3 W: 424.56
PCSK9-IN-16 is a potent PCSK9 inhibitor. PCSK9-IN-16 is extracted from patent WO2020150474, example 87, has the potentia
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.